Ureteral Reimplantation — Cost, Top Hospitals & Success Rates | MyMedicPlus

Ureteral reimplantation (ureteroneocystostomy) is a surgical procedure in which the ureter — the muscular tube connecting the kidney to the bladder — is detached from its current bladder attachment point and reinserted into the bladder wall at a new, surgically created site. The procedure is performed primarily to correct vesicoureteral reflux (VUR) — the abnormal retrograde flow of urine from the bladder back toward the kidney — and to repair ureteral injuries or obstructions at the ureterovesical junction (UVJ).

Under normal anatomy, the ureter enters the bladder obliquely through a tunnel within the bladder muscle (detrusor), creating a valve-like mechanism: as the bladder fills and contracts, the tunnel is compressed, preventing urine from refluxing upward. When this intravesical tunnel is too short or absent, the anti-reflux mechanism fails, allowing bacteria-laden bladder urine to reach the kidney with each void — a major risk factor for febrile urinary tract infections (UTIs), pyelonephritis, and, in severe or recurrent cases, renal scarring that can lead to hypertension and chronic kidney disease.

VUR is classified by the International Reflux Study Committee (IRSC) grading system (grades I–V): Grade I (reflux into ureter only) through Grade V (gross dilatation and tortuosity of ureter and pelvicalyceal system with intraparenchymal reflux). Surgery is generally reserved for grades III–V or lower grades that have failed conservative management.

The fundamental principle of all ureteral reimplantation techniques is the creation of an adequate submucosal tunnel with a tunnel-to-ureter diameter ratio of at least 5:1. This ratio ensures reliable valve competence. The specific technique chosen depends on patient age, grade of VUR, bladder anatomy, and surgeon preference — the three principal techniques being Politano-Leadbetter (intravesical), Cohen (intravesical cross-trigonal), and Lich-Gregoir (extravesical).

Ureteral reimplantation addresses pathological conditions at or near the ureterovesical junction:

Vesicoureteral Reflux (VUR) — Primary

Primary VUR results from a congenitally short intravesical ureteral tunnel without any other underlying bladder pathology. It is the most common urological anomaly in children, affecting approximately 1% of all children and found in 30–50% of children investigated after a febrile UTI. Girls are affected more often clinically (due to shorter urethral length and higher UTI rates), but the prevalence of VUR is similar in both sexes. There is a strong familial predisposition — siblings of affected children have a 25–35% chance of VUR and should be screened. Most grades I–II VUR resolve spontaneously as the child grows and the ureteral tunnel lengthens; surgery is typically considered for grades III–V, bilateral high-grade reflux, or reflux persisting after puberty.

Vesicoureteral Reflux — Secondary

Secondary VUR results from elevated bladder pressure overcoming an otherwise competent UVJ, typically caused by bladder outlet obstruction (posterior urethral valves in boys), neuropathic bladder (myelomeningocele, sacral agenesis), or bladder dysfunction. Management must address the underlying voiding dysfunction in addition to the reflux itself; reimplantation without treating the primary cause has a high failure rate.

Ureteral Injury at the UVJ

Iatrogenic ureteral injury is a recognised complication of gynaecological surgery (hysterectomy, uterosacral ligament suspension), colorectal surgery, and urological procedures. Injuries at the distal ureter (most common site) may require reimplantation — either immediate (if recognised intraoperatively) or delayed (if presenting with urinoma, obstruction, or fistula in the post-operative period). A psoas hitch or Boari flap may be required to bridge the gap between the cut ureter end and the bladder without tension.

Obstructive UVJ Stenosis

Congenital or acquired stenosis (from calculi, inflammatory scarring, or prior surgery) at the UVJ producing unilateral hydronephrosis and deteriorating renal function may require reimplantation after endoscopic approaches (balloon dilation, endoureterotomy) have failed or are contraindicated.

The decision to proceed to ureteral reimplantation rather than continue conservative management is based on the grade of VUR, the clinical course, renal function, and bladder dynamics.

Indications for Surgery in VUR

• Grade IV or V VUR in any age group, particularly with renal scarring on DMSA (dimercaptosuccinic acid) scintigraphy
• Grade III VUR with breakthrough febrile UTIs despite continuous antibiotic prophylaxis (trimethoprim or nitrofurantoin)
• Bilateral Grade III VUR in children over 5 years unlikely to resolve spontaneously
• Any grade VUR persisting beyond puberty in females (where the risk of VUR-related complications during pregnancy is significant)
• Allergy or non-compliance with antibiotic prophylaxis in children with high-grade VUR
• VUR associated with new or progressive renal scarring on sequential DMSA scanning
• Patient or parental preference for surgical resolution over prolonged antibiotic prophylaxis

Pre-Operative Work-Up

• MCUG (micturating cystourethrogram): Gold standard for VUR grading and bladder assessment
• DMSA renal scan: Identifies existing renal scarring and quantifies differential renal function
• Ultrasound renal tract: Baseline upper tract anatomy; identifies hydroureteronephrosis
• Urodynamics: In children with suspected bladder dysfunction, overactive bladder, or secondary VUR — bladder dynamics must be optimised before surgery
• Urine culture: Surgery should be deferred until infection is eradicated

Contraindications

• Active urinary tract infection at time of surgery
• Untreated bladder outlet obstruction or neuropathic bladder dysfunction
• Single functioning kidney (requires specialist risk counselling)
• Significant comorbidity limiting general anaesthetic fitness

Three principal surgical techniques for ureteral reimplantation are in widespread use, each with specific anatomical and clinical indications:

Cohen (Cross-Trigonal) Technique — Intravesical

The bladder is opened (cystotomy), the ureter is detached from its original hiatus, and then tunnelled transversely across the trigone to the contralateral side of the bladder, where it is anastomosed submucosally. The new tunnel achieves the 5:1 length-to-diameter ratio required for anti-reflux competence. The Cohen technique is the most widely used intravesical approach globally, with reported success rates of 96–99% for grades III–IV VUR. Its principal disadvantage is that the transverse reimplantation site makes subsequent ureteral access with a cystoscope technically challenging, which is relevant if the patient ever requires ureteroscopy for stones or stricture.

Politano-Leadbetter Technique — Intravesical

The ureter is detached from its original hiatus and reinserted through a new, more superiorly positioned hiatus in the bladder wall, then tunnelled submucosally downward to the trigone. This recreates a more anatomical ureteral course. The new hiatus is positioned to avoid kinking of the ureter. Success rates are comparable to Cohen (95–97%), and the more superior reimplantation site allows easier subsequent cystoscopic access. Technical complexity is slightly higher, particularly in small infant bladders.

Lich-Gregoir (Extravesical) Technique

This approach does not open the bladder. Through an extraperitoneal or laparoscopic approach, the detrusor muscle is incised to create a trough without entering the bladder lumen. The terminal ureter is laid into this trough and the detrusor is closed over it, creating a submucosal tunnel from outside the bladder. Blood loss is minimal, catheter time is reduced (24–48 hours), and recovery is faster. Success rates of 94–98% are reported. However, bilateral Lich-Gregoir reimplantation carries a risk of transient bilateral ureteral oedema causing post-operative urinary retention (3–5%). It is therefore often staged (one side at a time in bilateral cases) or avoided in patients with a solitary kidney.

Laparoscopic and Robot-Assisted Reimplantation

Robot-assisted laparoscopic ureteral reimplantation using the da Vinci platform replicates the Lich-Gregoir extravesical approach with enhanced visualisation and precision. Outcomes approach those of open surgery in experienced hands. Laparoscopic intravesical reimplantation (pneumovesicoscopy) replicates the Cohen technique endoscopically. Both minimally invasive approaches offer reduced hospital stay and faster recovery, though operative times remain longer than open surgery and are available only in specialist paediatric urology centres.

Endoscopic Injection (STING/HIT Procedure)

A bulking agent (dextranomer-hyaluronic acid copolymer, Deflux) is injected cystoscopically below the ureteral orifice to create a submucosal bulge that acts as a mechanical reflux barrier. This office-based or day-case procedure avoids open surgery. Success rates for a single injection are 70–85% for grade III, 60–75% for grade IV, and 50–60% for grade V — significantly lower than open reimplantation. It is a reasonable first-line intervention for grades II–IV VUR when surgical intervention is desired but parents or patients prefer the least invasive option first.

Successful ureteral reimplantation provides durable correction of VUR and protection of the upper urinary tract from ongoing damage.

VUR Resolution

Open ureteral reimplantation achieves complete resolution of VUR (grade 0 on post-operative MCUG) in 94–99% of cases across all three major techniques for primary VUR grades III–V. This is substantially superior to endoscopic injection (70–85% for a single treatment) and provides long-term, typically lifelong, anti-reflux protection. Revision surgery following failed reimplantation is required in only 1–2% of cases.

Reduction in Febrile UTIs and Pyelonephritis

The most clinically significant benefit is elimination of recurrent febrile UTIs and pyelonephritis, which are the direct mechanism by which VUR damages the kidney. Multiple prospective studies demonstrate a significant reduction in UTI frequency following successful reimplantation. The International Reflux Study in Children showed that surgical management reduced febrile UTI incidence more effectively than medical management alone in grades III–IV VUR.

Prevention of Progressive Renal Scarring

Renal scarring from recurrent pyelonephritis is cumulative and irreversible. Successful early reimplantation in children with high-grade VUR arrests this process and prevents progressive scarring. Serial DMSA scans post-operatively demonstrate stable scarring without new lesions in the vast majority of successfully operated patients.

Freedom from Antibiotic Prophylaxis

Patients with VUR often require low-dose continuous antibiotic prophylaxis for months to years. Following successful reimplantation, prophylaxis is discontinued at 3 months if the post-operative MCUG confirms VUR resolution — eliminating antibiotic exposure, resistance risk, and the compliance burden on families with young children.

Ureteral reimplantation is generally very well tolerated with low complication rates in experienced paediatric urology and adult urological surgery centres, but potential complications must be discussed pre-operatively.

Common (1–5%)

• Transient haematuria: Expected following cystotomy; resolves within 24–48 hours as irrigation clears the bladder.
• Urinary retention: Particularly relevant following bilateral extravesical (Lich-Gregoir) reimplantation due to temporary oedema at both ureteral orifices. Usually resolves within 5–7 days with catheter drainage.
• Urinary tract infection: Despite prophylaxis, perioperative UTI occurs in 2–5% of cases; treated with culture-directed antibiotics.
• Bladder spasms: Common in children in the immediate post-operative period; managed with anticholinergic medication (oxybutynin) and adequate analgesia.

Uncommon (0.5–2%)

• Ureteral obstruction (stenosis at anastomosis): The most clinically significant complication, occurring when the tunnel is too tight or periureteral scarring develops. Presents with flank pain, hydronephrosis, and rising creatinine. May require balloon dilation, endoureterotomy, or revision reimplantation.
• Persistent VUR: Occurs in 1–5% of cases; usually low-grade and often managed conservatively. High-grade persistence requires revision.
• Ureteral devascularisation: Aggressive ureteral mobilisation can compromise the delicate ureteral blood supply, leading to stricture formation weeks to months post-operatively. Careful preservation of periureteral adventitia during dissection is essential.

Rare but Serious

• Ureteral fistula or leak at anastomosis (managed with prolonged catheter drainage or surgical revision)
• Ileus from extraperitoneal dissection
• Pelvic haematoma
• Contralateral ureteral injury (intraoperative recognition essential)

Long-term surveillance with annual blood pressure measurement and urinalysis is recommended in children who had pre-operative renal scarring, as hypertension can develop decades after VUR-associated renal damage — unrelated to the success of the reimplantation itself.

Post-operative care after ureteral reimplantation is straightforward but requires careful monitoring of the ureteral anastomosis and upper urinary tract in the weeks following surgery.

Immediate Post-Operative Period (Days 1–4)

A urethral catheter is maintained for 24–48 hours (extravesical techniques) or 2–5 days (intravesical techniques requiring cystotomy closure) to decompress the bladder and reduce anastomotic tension. Ureteral stents — thin silicone tubes placed across the reimplantation site — may be used at the surgeon's discretion, typically removed at 6–8 weeks at cystoscopy. Intravenous fluids maintain urine output. Post-operative pain is moderate and well managed with paracetamol ± NSAIDs; opioid analgesia is rarely required beyond 24–48 hours. Most children are mobile and tolerating oral fluids by day 2 and are discharged home by day 3–4.

Home Care and Activity

Following discharge, families are instructed to maintain adequate oral hydration, monitor for fever (which may indicate UTI or ureteral obstruction), and ensure the child avoids straddle activities or contact sports for 4–6 weeks while the anastomosis heals. Oral trimethoprim prophylaxis is continued until VUR resolution is confirmed post-operatively. Older children and adults typically return to desk work at 2–3 weeks and full physical activity by 6 weeks.

Post-Operative MCUG (Micturating Cystourethrogram)

A MCUG is performed at 3 months post-operatively to confirm VUR resolution. If VUR has resolved (grade 0), antibiotic prophylaxis is discontinued. If low-grade reflux persists, a further 6-month period of observation with prophylaxis is reasonable. Persistent high-grade VUR requires urological review to determine whether revision surgery is indicated.

Renal Surveillance

Children with pre-operative DMSA scarring require 12-monthly blood pressure monitoring and annual dipstick urinalysis for proteinuria throughout childhood and into adulthood. A repeat DMSA scan at 12 months post-operatively documents whether new scarring has occurred following surgery. Those with significant bilateral scarring and reduced total GFR (<60 ml/min/1.73m²) require nephrology co-management.

Ureteral reimplantation in children is often covered by public health insurance or national health service provision in countries with universal healthcare. Adult reimplantation for iatrogenic injury is typically covered as part of the original surgical episode. Private or out-of-pocket costs vary significantly by country.

Approximate Cost Ranges by Region

• United States: USD 15,000–40,000 (open surgery, without insurance); robotic-assisted procedures cost USD 25,000–55,000
• United Kingdom (private): GBP 7,000–15,000
• India (specialist paediatric urology centres, JCI/NABH): USD 2,500–6,000 (open); USD 4,000–9,000 (robotic/laparoscopic)
• Thailand: USD 5,000–12,000
• Turkey: USD 4,000–10,000
• Singapore: USD 8,000–18,000

Key Cost Drivers

• Unilateral vs. bilateral: Bilateral reimplantation is significantly more complex and time-consuming, particularly in small children
• Open vs. robotic: Robot-assisted surgery adds USD 2,000–5,000 in equipment costs but may reduce hospital stay
• Paediatric vs. adult: Specialist paediatric urology units with appropriate paediatric anaesthesia and nursing care command appropriate fee premiums
• Post-operative imaging: DMSA renal scintigraphy (USD 400–1,000) and MCUG (USD 300–700) add to the total episode cost
• Associated procedures: Concurrent adenoidectomy, circumcision in boys with phimosis predisposing to UTI, or bladder neck procedures in neuropathic bladder increase total cost

For families travelling internationally with children requiring this surgery, it is essential to choose a facility with a dedicated paediatric urology team including specialist paediatric anaesthesia, age-appropriate nursing care, and a clear protocol for post-operative surveillance including post-operative MCUG. Verify that follow-up imaging can be performed locally and that results will be communicated to the operating centre.

For VUR, a spectrum of management options exists between no treatment and open reimplantation. The appropriate choice depends on the grade of reflux, the patient's age, renal function, and UTI history.

Watchful Waiting (Surveillance without Prophylaxis)

Low-grade VUR (grades I–II) in children under 5 years frequently resolves spontaneously as the bladder grows and the intravesical ureteral tunnel lengthens. Randomised controlled trials (RIVUR, Swedish Reflux Trial) demonstrate that grades I–II can be safely observed without prophylaxis if the child is closely monitored and parents are able to respond promptly to febrile illness. Spontaneous resolution rates at 5 years are approximately 80% for grade II and 50% for grade III.

Continuous Low-Dose Antibiotic Prophylaxis (CAP)

Trimethoprim or nitrofurantoin at one-quarter to one-half of the therapeutic dose given nightly prevents UTI in the presence of VUR. The RIVUR trial demonstrated that prophylaxis reduces febrile UTI recurrence by 50% compared to placebo in children with VUR grades I–IV. CAP is the standard initial medical management for VUR and is continued until reflux resolves spontaneously or surgery is performed. Concerns about antibiotic resistance with prolonged use have increased interest in surgical correction in high-grade cases.

Endoscopic STING Injection (Deflux)

As described in the treatment options section, submucosal injection of dextranomer-hyaluronic acid (Dx/HA, Deflux) beneath the ureteral orifice is the least invasive surgical option. It is performed under brief general anaesthesia as a day-case procedure with success rates of 70–85% for grades III–IV and requires repeat injection in a minority of cases. It is an appropriate alternative to open reimplantation for parents who prefer the least invasive approach, and for bilateral low-to-moderate grade VUR where open bilateral reimplantation carries a higher retention risk.

Bladder Dysfunction Management

In secondary VUR, addressing the underlying bladder dysfunction with anticholinergics (oxybutynin), timed voiding, and biofeedback-assisted pelvic floor training often resolves or significantly reduces the grade of VUR without direct ureteral surgery. Urodynamic assessment is essential before categorising VUR as primary in a child with any lower urinary tract symptoms.